JASPER THERAPEUTICS, INC. Other Current Liabilities
JASPER THERAPEUTICS, INC. (JSPR) had Other Current Liabilities of $392.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2023-11-09
- 2023-09-30: Other Liabilities, Current $392.00K.
- 2023-06-30: Other Liabilities, Current $389.00K.
- 2023-03-31: Other Liabilities, Current $426.00K.
- 2022-12-31: Other Liabilities, Current $194.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2023-09-30 | $392.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $389.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $426.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $194.00K 10-Q · filed 2023-11-09 |
| 2022-09-30 | $816.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $519.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $548.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $585.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $470.00K 10-Q · filed 2021-11-12 |
| 2020-12-31 | $149.00K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |